Literature DB >> 1724623

Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.

J A Mitchell1, H Sheng, U Förstermann, F Murad.   

Abstract

Tissue homogenates prepared from rat anococcygeus muscle converted L-arginine to L-citrulline indicating the presence of nitric oxide (NO) synthase. NO synthase activity was also found in crude and partially-purified soluble and particulate fractions prepared from the homogenates. Both soluble and particulate NO synthase were dependent on NADPH, 5,6,7,8-tetrahydrobiopterin and calcium, and inhibited by NG-nitro-L-arginine. Tissue homogenates or crude cytosolic and membrane fractions from rat vas deferens, which does not contain NO releasing non-adrenergic non-cholinergic neurones, had no NO synthase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724623      PMCID: PMC1908579          DOI: 10.1111/j.1476-5381.1991.tb12422.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin.

Authors:  B Mayer; M John; E Böhme
Journal:  FEBS Lett       Date:  1990-12-17       Impact factor: 4.124

3.  Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation.

Authors:  J A Mitchell; U Förstermann; T D Warner; J S Pollock; H H Schmidt; M Heller; F Murad
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

4.  The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

5.  L-NG-nitro-arginine and its methyl ester are potent inhibitors of non-adrenergic, non-cholinergic transmission in the rat anococcygeus.

Authors:  A J Hobbs; A Gibson
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

6.  Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.

Authors:  H H Schmidt; J S Pollock; M Nakane; L D Gorsky; U Förstermann; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

7.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

8.  Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.

Authors:  U Förstermann; J S Pollock; H H Schmidt; M Heller; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

9.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

10.  The rat anococcygeus muscle and its response to nerve stimulation and to some drugs.

Authors:  J S Gillespie
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

  10 in total
  20 in total

1.  Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles.

Authors:  H Sheng; H H Schmidt; M Nakane; J A Mitchell; J S Pollock; U Föstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 2.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

4.  The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat.

Authors:  N K Boughton-Smith; S M Evans; F Laszlo; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.

Authors:  C Thiemermann; C Szabó; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

6.  Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Authors:  C Szabó; J A Mitchell; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

7.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites.

Authors:  J P Cristol; C Thiemermann; J A Mitchell; C Walder; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Authors:  T A Swierkosz; J A Mitchell; T D Warner; R M Botting; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.

Authors:  Haroldo A Toque; Fernanda B M Priviero; Saiprasad M Zemse; Edson Antunes; Cleber E Teixeira; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-15       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.